Our data suggest that inhibition of wildtype IDH1, depletion of KG through glutamine restriction, or inhibition of carnitine synthesis may act as a novel therapeutic approach in these cancers
1 Remove AOD-9604 vial from refrigeration and allow to reach room temperature (1520 minutes) 2 Clean vial top with alcohol swab and allow to air dry completely 3 Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water) 4 Inject BAC water slowly down the side of the vial do not aim directly at the powder 5 Gently swirl in circular motions DO NOT shake vigorously as this degrades the peptide 6 Allow 23 minutes for full dissolution solution should be clear and colorless 7 Draw calculated dose into an insulin syringe for subcutaneous injection 8 Inject into abdomen, thigh, or upper arm
The peptide therapy program addresses Lyme disease, mold toxicity, and autoimmune disorders alongside standard wellness goals
10.1542/peds.2007-3022 18
These new dynamics are likely to significantly expand adoption. In Morgan Stanleys base-case scenario, nearly 30% of the obese or diabetic population in the U.S
Aftercare: Minimal aftercare is required, though applying an ice pack to the injection site can provide comfort